Moonlake Immunotherapeutics Ltd
13502700
Healthy
- No accounts filed in last 18 months (-5)
- 1 outstanding charge (-2)
Details
Compliance
Last accounts
31/12/2024
total exemption full
Next accounts due
30/09/2026
Confirmation statement
Last: 08/07/2025
Due 22/07/2026
Industry
Officers
Persons with Significant Control
Moonlake Immunotherapeutics Ag
Dorfstrasse 29, 6300 Zug, Bern
Reg: 433093536 · Switzerland · Private Company Limited By Shares
Notified 09/07/2021
Charges1 outstanding
Hercules Capital, Inc., as Security Trustee for the Secured Parties (As Defined in the Instrument)
No specific land, ship, aircraft or intellectual property has been charged. For full details of the charges, please refer to the charging document directly.
CompanyRankvs 1192+ SIC 72110 peers48
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2021
Net Worth
£1k
Balance sheet strength
Cash
£121k
Cash in the bank
Net Current Assets
£21k
Working capital
Current Assets
£141k
Current Liabilities
£119k
Debtors
£20k
Tax at Year End
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2021 | 1.18 |
Derived from filed accounts. Not audited figures.